| 1 |
Brisson L, Henrique Geraldo L, Bikfalvi A, Mathivet T. The strange Microenvironment of Glioblastoma. Rev Neurol (Paris) 2023:S0035-3787(23)00883-4. [PMID: 36964121 DOI: 10.1016/j.neurol.2023.03.007] [Reference Citation Analysis]
|
| 2 |
Chen P, Bi F, Tan W, Jian L, Yu X. A novel immune-related model to predict prognosis and responsiveness to checkpoint and angiogenesis blockade therapy in advanced renal cancer. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1127448] [Reference Citation Analysis]
|
| 3 |
Yang Y, Fu X, Liu R, Yan L, Yang Y. Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme. Front Genet 2022;13:1033572. [PMID: 36712881 DOI: 10.3389/fgene.2022.1033572] [Reference Citation Analysis]
|
| 4 |
Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest 2023;133. [PMID: 36594466 DOI: 10.1172/JCI163446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Tang L, Zhang R, Wang Y, Zhang X, Yang Y, Zhao B, Yang L. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration. Acta Biomater 2023;155:521-37. [PMID: 36384220 DOI: 10.1016/j.actbio.2022.11.013] [Reference Citation Analysis]
|
| 6 |
Zheng Y, Graeber MB. Microglia and Brain Macrophages as Drivers of Glioma Progression. Int J Mol Sci 2022;23. [PMID: 36555253 DOI: 10.3390/ijms232415612] [Reference Citation Analysis]
|
| 7 |
Zhao J, Dong Y, Zhang Y, Wang J, Wang Z. Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy. Adv Drug Deliv Rev 2022;191:114585. [PMID: 36273512 DOI: 10.1016/j.addr.2022.114585] [Reference Citation Analysis]
|
| 8 |
Sallam M, Mysara M, Baatout S, Guns PJ, Ramadan R, Benotmane MA. Meta-Analysis of RNA-Seq Datasets Identifies Novel Players in Glioblastoma. Cancers (Basel) 2022;14. [PMID: 36497269 DOI: 10.3390/cancers14235788] [Reference Citation Analysis]
|
| 9 |
Silver A, Feier D, Ghosh T, Rahman M, Huang J, Sarkisian MR, Deleyrolle LP. Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization. Front Oncol 2022;12:1022716. [PMID: 36338705 DOI: 10.3389/fonc.2022.1022716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Wang Z, Zhong H, Liang X, Ni S. Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape. Front Immunol 2022;13:1024921. [DOI: 10.3389/fimmu.2022.1024921] [Reference Citation Analysis]
|
| 11 |
Xu C, Xiao M, Li X, Xin L, Song J, Zhan Q, Wang C, Zhang Q, Yuan X, Tan Y, Fang C. Origin, activation, and targeted therapy of glioma-associated macrophages. Front Immunol 2022;13:974996. [DOI: 10.3389/fimmu.2022.974996] [Reference Citation Analysis]
|
| 12 |
Maitra M, Mitsuhashi H, Rahimian R, Chawla A, Yang J, Fiori L, Davoli M, Perlman K, Aouabed Z, Mash DC, Suderman M, Mechawar N, Turecki G, Nagy C. Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes.. [DOI: 10.1101/2022.09.23.509254] [Reference Citation Analysis]
|
| 13 |
Picca A, Finocchiaro G. Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results. Curr Opin Oncol 2022. [PMID: 36000367 DOI: 10.1097/CCO.0000000000000895] [Reference Citation Analysis]
|
| 14 |
Jacob L, de Brito Neto J, Lenck S, Corcy C, Benbelkacem F, Geraldo LH, Xu Y, Thomas J, El Kamouh M, Spajer M, Potier M, Haik S, Kalamarides M, Stankoff B, Lehericy S, Eichmann A, Thomas J. Conserved meningeal lymphatic drainage circuits in mice and humans. Journal of Experimental Medicine 2022;219:e20220035. [DOI: 10.1084/jem.20220035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Pang L, Khan F, Heimberger AB, Chen P. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma. Trends Cancer 2022:S2405-8033(22)00097-8. [PMID: 35624002 DOI: 10.1016/j.trecan.2022.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Omuro A. Immune-checkpoint inhibitors for glioblastoma: what have we learned? Arq Neuro-Psiquiatr 2022;80:266-269. [DOI: 10.1590/0004-282x-anp-2022-s129] [Reference Citation Analysis]
|
| 17 |
Pang L, Khan F, Dunterman M, Chen P. Pharmacological targeting of the tumor–immune symbiosis in glioblastoma. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.04.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Jacob L, de Brito Neto J, Lenck S, Corcy C, Benbelkacem F, Geraldo LH, Xu Y, Thomas J, El Kamouh M, Potier M, Haik S, Lehericy S, Eichmann A, Thomas J. 3D-imaging reveals conserved cerebrospinal fluid drainage via meningeal lymphatic vasculature in mice and humans.. [DOI: 10.1101/2022.01.13.476230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Zhang J, Luo Y, Feng M, Xia Q. Identification of Liver Immune Microenvironment-Related Hub Genes in Liver of Biliary Atresia. Front Pediatr 2021;9:786422. [PMID: 35111704 DOI: 10.3389/fped.2021.786422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
